SD4.F SPECTRAL MEDICAL

Healthcare Biotechnology Frankfurt Exchange
0.6500 EUR
Close of Nov 12, 2026
0.5500 0.9100
Market cap
EUR 191M
P/E
-
P/B
49.49x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SD4.F undervalued?

Graham number

The Graham number of SPECTRAL MEDICAL cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SPECTRAL MEDICAL fundamental analysis

No fundamental analysis for SPECTRAL MEDICAL yet.

SPECTRAL MEDICAL stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SPECTRAL MEDICAL

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal …

Full company profile